AIGR Gene Hypothesis Deep Research — *Saccharomyces cerevisiae* SSZ1 (P38788) OpenScientist openscientist-autonomous 8 citations 4 artifacts 2026-09-20T22:51:51.632608 citations file

AIGR Gene Hypothesis Deep Research — Saccharomyces cerevisiae SSZ1 (P38788)

Focus: function_assignment · Hypothesis slug: refolding-and-secondary-compartments
Source: genes/yeast/SSZ1/SSZ1-ai-review.yaml (free-text)
Gene: SSZ1 / PDR13 (Ribosome-associated complex subunit Ssz1) · UniProt: P38788 · PANTHER: PTHR19375, subfamily SF539


Summary

The seed hypothesis proposes three distinct claims that must be adjudicated separately: (1) that Ssz1 supports protein refolding, possibly via ATP-independent or partner-assisted mechanisms; (2) that Ssz1 localizes to the nucleus; and (3) that Ssz1 localizes to the plasma membrane. On the primary biology, all three fail — but for different reasons and with different current annotation states.

Protein refolding (GO:0042026) is not a genuine molecular function of Ssz1. Ssz1 is a well-characterized non-canonical Hsp70 that lacks the biochemical machinery required for the canonical refolding cycle: it is not an ATPase in vitro, its ATP-binding capacity is dispensable in vivo, and its peptide-substrate binding is not essential (PMID: 17901048). Its only measurable substrate interaction is transient, low-affinity, and dedicated to relaying nascent chains through the Ribosome-Associated Complex (RAC) to the folding Hsp70 Ssb — not to holding or refolding denatured/misfolded proteins (PMID: 32198371). The seed's specific question — whether ATPase-inactive Ssz1 could refold clients through ATP-independent or partner-assisted routes — is answered in the negative: Ssz1's partner-assisted role is to activate Ssb's ATPase and orient nascent chains, not to fold clients itself. The live GO record shows GO:0042026 present as a positive IBA propagated from the canonical-Hsp70 ancestor PTN000452648, with no NOT/IRD deployed anywhere in the family (0 hits family-wide). The seed's proposed IRD at PTN001065099 is biologically justified (that node is confirmed ancestral to Ssz1), but it is not currently in effect, so the positive IBA reaches Ssz1 unobstructed.

On localization, the plasma membrane (GO:0005886) annotation has already been removed from the live GO_Central set (it lingers only in a lagging UniProt cross-reference snapshot), so no new action is needed there. The nucleus (GO:0005634) annotation persists as a live IBA over-annotation propagated from canonical cytosolic Hsp70 paralogs (Ssa1–4, human HSPA) that genuinely shuttle to the nucleus, whereas Ssz1 is a stably ribosome-associated cytosolic chaperone whose only experimentally supported localization is cytoplasm/cytosol (GO:0005737, IDA). The most curation-relevant actions are therefore: (a) apply the IRD/NOT for refolding at PTN001065099 or otherwise block/remove the refolding IBA, and (b) remove the nucleus IBA over-annotation. Overall verdict: refuted (biology) / over-annotated (annotations), with the plasma-membrane component already resolved.


Executive Judgment

Verdict: Refuted (biology) / Over-annotated (annotations); plasma-membrane component already resolved.

Each of the three seed claims is adjudicated separately below:

Most important caveats: This adjudication rests on live public GO/PANTHER/QuickGO state plus primary literature; it does not include the withheld local bioinformatics analyses. The refolding refutation is a mechanistic-plus-annotation judgment (absence of mechanism + absence of experimental evidence), not a dedicated null experiment. The seed's proposed IRD/NOT correction is topologically valid but not currently deployed.


Key Findings

F001 — Protein refolding (GO:0042026) is not experimentally supported; the positive IBA is over-annotation

The GO term GO:0042026 "protein refolding" on P38788 carries the evidence code IBA only (phylogenetic inference; ECO:0000318, GO_REF:0000033, assigned by GO_Central). There is no IDA, IMP, or other experimental (EXP-class) evidence anywhere in the record supporting Ssz1 as a refoldase.

The primary literature explains why this is mechanistically expected. Conz et al. (2007) directly demonstrated that "Ssz1 is not an ATPase in vitro, and even its ability to bind ATP is dispensable in vivo" (PMID: 17901048). Canonical Hsp70-driven refolding is an ATP-hydrolysis-powered clamp-and-release cycle; an Hsp70 that neither hydrolyzes ATP nor requires ATP binding cannot execute that cycle. Furthermore, Zhang et al. (2020) showed that "the combined data indicate that Ssz1 is an active chaperone optimized for transient, low-affinity substrate binding, which ensures the flux of nascent chains through RAC/Ssb" (PMID: 32198371). Transient, low-affinity binding is the opposite of the stable "holdase" grip needed to sequester and refold a denatured client. Together, the two mechanistic requirements for canonical refolding — an ATPase cycle and stable substrate holding — are both absent in Ssz1. The seed's question about ATP-independent or partner-assisted refolding is thereby directly addressed: Ssz1's partner-assisted contribution is to stimulate Ssb (via Zuo1's J-domain) and to relay substrate, not to refold clients itself.

F002 — PANTHER PTN001065099 is genuinely ancestral to SSZ1, so an IRD there would validly block refolding propagation

A programmatic trace of PANTHER tree PTHR19375 (release 19) places SSZ1/P38788 (subfamily SF539) on a lineage passing through PTN000452648 (LUCA-level Hsp70 ancestor, SF184) → … → PTN001065099 (Fungi node, SF395) → PTN002321669 (Dikarya divergence, SF539) → … → P38788. Both nodes cited in the seed are confirmed ancestors of Ssz1 (membership check: PTN001065099 ∈ ancestor set = True; PTN000452648 ∈ ancestor set = True). Consequently, a PAINT NOT/IRD (Inferred from Rapid Divergence) for GO:0042026 placed at PTN001065099 would propagate a loss-of-ancestral-function down to the SSZ1 clade — i.e., the seed's proposed mechanism for correcting the annotation is topologically valid.

F004 — Live GO state: refolding is an un-blocked positive IBA from PTN000452648; no NOT/IRD is currently deployed

QuickGO (EBI) for P38788 returns 26 annotations. GO:0042026 "protein refolding" appears as a positive IBA (qualifier involved_in, ECO:0000318, GO_REF:0000033, assigned by GO_Central), whose withFrom seeds are canonical Hsp70 refoldases propagated from ancestral node PTN000452648 (including SGD S000000004 = SSA1, plus human HSPA members P0DMV8/P0DMV9/P11142/P17066/P34931 and SGD S000003806). A family-wide QuickGO query for GO:0042026 with qualifier=NOT returns 0 hits across all species — so no NOT/IRD loss for protein refolding is deployed anywhere, including at PTN001065099. This is the crux for the curator: the biology says the term should be blocked at the Fungi node, PANTHER topology confirms a block there would reach Ssz1, but the block does not currently exist, so the term flows through unobstructed.

F003 & F005 — Nucleus and plasma-membrane annotations are phylogenetic-only over-annotations; plasma membrane is already removed

For P38788, GO:0005634 "nucleus" and GO:0005886 "plasma membrane" carry IBA:GO_Central only. The only experimentally supported localization is cytoplasm/cytosol: GO:0005737 cytoplasm IDA:SGD, and the UniProt curated Subcellular Location = Cytoplasm. These CC terms are propagated at the PTHR19375 family GO-slim level as a carry-over from canonical cytosolic Hsp70s (Ssa1–4, human HSPA) that genuinely shuttle to the nucleus and associate with membranes.

Critically, the live state differs from the static UniProt snapshot:

Ssz1's only well-documented extraribosomal function — posttranslational activation of the transcription factor Pdr1 — does not establish stable nuclear residence. Hallstrom & Moye-Rowley showed "Pdr13p exerts its effect on Pdr1p at a posttranslational step" (PMID: 9488429), and the experimentally supported cytoplasmic localization is documented in Mol Microbiol 2000 (PMID: 10792726), where "Hyperactive forms of the Pdr1p transcription factor fail to respond to positive regulation by the hsp70 protein Pdr13p." Acting posttranslationally on a transcription factor is not evidence that Ssz1 itself resides in the nucleus.

F006 — Ssz1's only experimentally-supported MF interactions are with RAC partner Zuo1, not with refolding clients

Live QuickGO for P38788: all four IPI "protein binding" (GO:0005515) annotations are withFrom P32527 = ZUO1 (PMIDs 11274393, 16429126, 23202586, 37968396); "heat shock protein binding" (GO:0031072, IPI) and "protein-folding chaperone binding" (GO:0051087, IPI) are withFrom SGD S000003517 = ZUO1. No experimental annotation records Ssz1 binding or refolding a denatured/misfolded client. The direct, experimentally supported chaperone-role annotations are the RAC-context terms GO:0051083 "de novo cotranslational protein folding" (IDA/IMP, PMID: 11274393) and complex membership GO:0101031. This confirms that the experimentally grounded function of Ssz1 is a structural/regulatory subunit of RAC that hands nascent chains to Ssb, not an autonomous refoldase.


Mechanistic Model / Interpretation

Ssz1 is the atypical Hsp70 subunit of the Ribosome-Associated Complex (RAC), an obligate heterodimer with the J-domain protein Zuo1 (Zuotin). RAC docks at the ribosomal polypeptide exit tunnel and functions as a co-chaperone that activates a third Hsp70, Ssb, which is the actual nascent-chain-binding folding chaperone. The division of labor is the key to adjudicating this hypothesis:

   Nascent chain emerging from ribosome tunnel
  │
  ▼
┌──────────────────────┐
│        RAC           │
│  ┌────────┐  ┌─────┐ │
│  │ Ssz1   │──│Zuo1 │ │   Ssz1 = atypical Hsp70:
│  │(non-   │  │(J-  │ │     • NOT an ATPase (PMID 17901048)
│  │ canon. │  │dom) │ │     • ATP-binding dispensable in vivo
│  │ Hsp70) │  └──┬──┘ │     • transient/low-affinity binding
│  └────────┘     │    │       (PMID 32198371)
└─────────────────┼────┘
          │ J-domain stimulates
          ▼
    ┌──────────┐
    │   Ssb    │  ← canonical Hsp70; ATP-driven;
    │ (ATPase) │    actually folds nascent chain
    └──────────┘
          │
          ▼
    Co-translational de novo folding
    (GO:0051083 — the correct BP term)

   Refolding of ALREADY-DENATURED proteins (GO:0042026):
   requires ATP-hydrolysis clamp cycle + stable holding
   → Ssz1 possesses NEITHER → NOT a refoldase

The seed's core mechanistic question is whether ATPase-inactive Ssz1 could still refold clients by "ATP-independent or partner-assisted mechanisms beyond its nascent-chain relay." The literature answers directly: Ssz1's partner-assisted role is to help activate Ssb and orient/relay nascent chains — its transient, low-affinity binding is optimized for flux, not for the stable sequestration that refolding demands. Structural studies reinforce this: RAC is held together by a tight Ssz1-SBD–Zuo1 interaction, with Ssz1 positioning Zuo1 to activate Ssb (PMID: 37081320); RAC is autoinhibited without a nascent chain and remodels to expose the Zuo1 J-domain to Ssb (PMID: 35701497); and Ssb(ATP) heterodimerizes with Ssz1 as the first step of an engagement pathway (PMID: 34580293). None of these attribute autonomous client folding to Ssz1.

The annotation over-reach arises from PANTHER family PTHR19375 grouping Ssz1 with canonical, ATP-driven, nucleus-shuttling cytosolic Hsp70s. Ancestral GO functions (refolding; nuclear/PM localization) are legitimately inferred for the canonical branch and then propagated by IBA to all descendants, including the rapidly diverged, function-specialized Ssz1 subfamily. This is a textbook case where IRD/NOT annotations at the divergence node exist precisely to prevent inherited-but-lost functions from leaking onto specialized paralogs.

Annotation state summary:

Term GO ID Ontology Live GO evidence Experimentally supported? Recommended action
protein refolding GO:0042026 BP Positive IBA from PTN000452648; no NOT deployed No (IBA only) Block via IRD/NOT at PTN001065099, or remove IBA
nucleus GO:0005634 CC Live IBA (is_active_in) from PTN002500132 No (IBA only) Remove (paralog-driven over-annotation)
plasma membrane GO:0005886 CC Absent from live QuickGO; only in lagging UniProt xref No Already resolved; note xref lag
cytoplasm GO:0005737 CC IDA:SGD (PMID:10792726) Yes Retain
de novo cotranslational protein folding GO:0051083 BP IDA/IMP (PMID:11274393) Yes Retain (this is the correct BP)
protein-folding chaperone binding / HSP binding GO:0051087 / GO:0031072 MF IPI withFrom ZUO1 Yes (Zuo1) Retain

Evidence Base / Evidence Matrix

Citation (PMID) Evidence type Supports/Refutes/Qualifies Claim tested Key finding Context Confidence & limitations
17901048 Conz et al. 2007 Direct assay + mutant phenotype Refutes refolding Does Ssz1 have canonical Hsp70 ATPase/ATP-binding required for refolding? "Ssz1 is not an ATPase in vitro, and even its ability to bind ATP is dispensable in vivo" S. cerevisiae, in vitro + in vivo High; establishes absence of canonical mechanism
32198371 Zhang et al. 2020 Direct assay Refutes/qualifies refolding Nature of Ssz1 substrate binding "active chaperone optimized for transient, low-affinity substrate binding... ensures the flux of nascent chains through RAC/Ssb" S. cerevisiae RAC High; shows relay, not holdase/refoldase role
9488429 Hallstrom & Moye-Rowley 1998 Mutant phenotype / genetics Qualifies nucleus Is Ssz1's Pdr1 effect nuclear-resident? "Pdr13p exerts its effect on Pdr1p at a posttranslational step" S. cerevisiae High; extraribosomal role does not require stable nuclear residence
10792726 Mol Microbiol 2000 Localization (IDA) Supports cytoplasm Where does Ssz1 reside? Cytoplasmic localization; Hsp70 Pdr13p regulates Pdr1p S. cerevisiae Basis for the only experimental CC term
11274393 Direct assay/interaction Supports RAC role Ssz1 function on the ribosome de novo cotranslational protein folding; Ssz1–Zuo1 interaction S. cerevisiae Basis for GO:0051083 and Zuo1 IPI
37081320 RAC cryo-EM 2023 Structural Qualifies mechanism RAC architecture / Ssz1 role Ssz1 SBD–Zuo1 interaction holds RAC together; Zuo1 positions Ssb for activation C. thermophilum RAC on 80S Structural basis: Ssz1 is scaffold/activator, not client-folder
35701497 RAC remodeling 2022 Structural Qualifies mechanism RAC dynamics during folding RAC autoinhibited without nascent chain; remodels to expose Zuo1 J-domain to Ssb S. cerevisiae Reinforces relay/activation model
34580293 Pathway of Hsp70 at ribosome 2021 Direct assay (crosslinking) Qualifies mechanism How Ssb engages ribosome via Ssz1 Ssb(ATP) heterodimerizes with Ssz1; Ssz1 tethered by Zuo1 S. cerevisiae Ssz1 role = positioning Ssb, not folding clients
11929994 Functional chaperone triad 2002 Direct assay/genetics Qualifies mechanism Ssz1/RAC/Ssb act in concert Efficient nascent-chain crosslink to Ssb depends on functional RAC S. cerevisiae Ssz1 acts on nascent chains, in concert with Ssb/Zuo1
28771464 RAC review 2017 Review Orientation Ssz1/RAC function summary "unconventional Hsp70 homolog Ssz1"; RAC stimulates Ssb ATPase Review Review-level; consistent with primary data
PANTHER PTHR19375 v19 Computational/evolutionary Supports curation action Is PTN001065099 ancestral to Ssz1? Both PTN001065099 and PTN000452648 confirmed on Ssz1 lineage Phylogenetic tree High for topology; IRD not yet deployed
QuickGO/GO_Central (P38788) Database Supports over-annotation call Live evidence codes for disputed terms Refolding = positive IBA, 0 NOT hits family-wide; PM absent; nucleus live IBA GO snapshot 2026 Database-level; reflects live state

GO Curation Implications

The evidence supports the following as leads requiring curator verification:


Mechanistic Scope

The immediate molecular function under test is whether Ssz1 directly performs protein refolding — i.e., ATP-dependent (or ATP-independent) recognition, holding, and productive folding of an already-denatured or misfolded client. The evidence indicates Ssz1's direct activity is instead: (i) serving as the structural Hsp70 subunit that, with Zuo1, forms RAC; (ii) tethering to the ribosome via Zuo1; and (iii) contributing to the transient, low-affinity relay of nascent chains toward Ssb, whose ATPase Zuo1 activates. Refolding of denatured clients, nuclear residence, and plasma-membrane residence are not direct Ssz1 activities. The Pdr1-activation phenotype is a downstream, posttranslational regulatory effect, not evidence of nuclear localization. The disputed CC terms are propagation artifacts, not observed localizations.


Conflicts and Alternatives

The dominant alternative explanation for every disputed annotation is paralog confusion within PANTHER family PTHR19375. Ssz1 is grouped with canonical cytosolic Hsp70s (Ssa1–4, human HSPA) that are bona fide ATP-driven refoldases and do shuttle to the nucleus. IBA propagation legitimately assigns those ancestral functions across the family but fails to account for Ssz1's rapid functional divergence into a specialized, ATPase-dead RAC scaffold. No organism-specific or isoform-specific finding rescues the refolding or nucleus claims; the structural literature (PMIDs 37081320, 35701497, 34580293, 11929994) uniformly casts Ssz1 as a scaffold/activator that positions Ssb, reinforcing rather than conflicting with the refutation. The only genuine extraribosomal role (Pdr1 activation) acts posttranslationally and does not require stable nuclear or membrane localization. No conflicting primary evidence supporting autonomous refolding or stable nucleus/PM residence of Ssz1 was found.


Limitations and Knowledge Gaps

  1. The refolding IBA is un-blocked but the IRD is not deployed. The seed proposes inspecting a NOT/IRD at PTN001065099, but the live check found 0 NOT annotations family-wide for GO:0042026. Gap: is the absence of the IRD an intentional curator decision or an un-curated node? Resolution: a curator should confirm whether GO_Central intends to place the IRD at the Fungi node or to correct by direct removal on Ssz1.

  2. Node identity for the nucleus propagation. The nucleus IBA is propagated from PTN002500132 (per QuickGO withFrom seeds), whereas the refolding IBA comes from PTN000452648; the seed only names PTN001065099/PTN000452648. Gap: the exact ancestral node for each disputed term should be verified in the current PANTHER release before an IRD strategy is chosen; the fix for nucleus may differ from the fix for refolding.

  3. UniProt xref lag. The plasma-membrane term persists in the UniProt cross-reference snapshot though absent from live GO_Central. Curators relying on the UniProt snapshot could mistakenly re-litigate an already-resolved term. Resolution: verify against live QuickGO/GO_Central, not the static xref.

  4. No dedicated experimental null for Ssz1 as an autonomous stress refoldase. The refutation rests on absence of a mechanism (no ATPase, transient binding) and absence of a positive experimental annotation — not on an experiment showing Ssz1 fails to refold a model substrate (e.g., denatured luciferase). This is a reasonable inference but not a direct null result.

  5. Withheld local bioinformatics. The local *-bioinformatics analyses were intentionally withheld from this run; this report should be reconciled against them.


Discriminating Tests

To decisively separate the seed hypothesis from the established relay model:

  1. In vitro refolding assay: Test purified Ssz1 (± Zuo1, ± Ssb, ± ATP) for the ability to refold a chemically or thermally denatured model substrate (firefly luciferase, MDH). Prediction under refutation: Ssz1 alone shows no ATP-dependent refolding; any activity requires the full Ssb-containing triad and is attributable to Ssb.
  2. ATP-independence probe: Repeat (1) with the ATP-binding-dead Ssz1 mutant. Prediction: no change relative to WT Ssz1, consistent with ATP-binding being dispensable (PMID:17901048).
  3. Localization by high-resolution imaging / fractionation: Quantitative confocal + subcellular fractionation under basal and heat-shock conditions to test for any nuclear or plasma-membrane Ssz1 pool beyond the ribosome-associated cytosolic fraction. Prediction: cytosolic/ribosomal only.
  4. PANTHER curation simulation: Deploy a test IRD for GO:0042026 at PTN001065099 in a sandbox and confirm the positive IBA to P38788 is suppressed — validating F002/F004 as a curation lead.
  5. Client-capture assay: In vivo crosslinking / proximity labeling from Ssz1 to identify whether any denatured-client interactions exist outside the nascent-chain context. Prediction: interactions dominated by Zuo1/Ssb and nascent chains, not mature misfolded clients.

Curation Leads (require curator verification)

Lead 1 — Protein refolding (GO:0042026) over-annotation.
- Action: Remove or block the positive IBA on P38788. Preferred mechanism per seed: deploy a PAINT NOT/IRD for GO:0042026 at PTN001065099 (confirmed ancestral to Ssz1 in PANTHER v19), suppressing propagation to the SSZ1 clade.
- Justification snippets to verify:
- PMID:17901048 — "Ssz1 is not an ATPase in vitro, and even its ability to bind ATP is dispensable in vivo."
- PMID:32198371 — "the combined data indicate that Ssz1 is an active chaperone optimized for transient, low-affinity substrate binding, which ensures the flux of nascent chains through RAC/Ssb."
- Note: Verify whether the missing IRD (0 NOT hits family-wide) is intentional or un-curated.

Lead 2 — Nucleus (GO:0005634) over-annotation.
- Action: Remove the live IBA is_active_in nucleus annotation as a paralog-driven propagation from canonical cytosolic Hsp70s; retain only cytoplasm (GO:0005737, IDA).
- Justification snippet: PMID:9488429 — "Genetic and Western blotting experiments indicated that Pdr13p exerts its effect on Pdr1p at a posttranslational step" (extraribosomal role that does not establish stable nuclear residence).

Lead 3 — Plasma membrane (GO:0005886).
- Action: No new action; already absent from live GO_Central. Flag the UniProt cross-reference snapshot as lagging.

Lead 4 — Retain the correct positive annotations.
- Retain GO:0051083 "de novo cotranslational protein folding" (BP; IDA/IMP, PMID:11274393), GO:0005737 cytoplasm (CC; IDA, PMID:10792726), and the Zuo1-based MF interaction terms (GO:0051087 protein-folding chaperone binding; GO:0031072 heat shock protein binding). These, not refolding, represent Ssz1's primary function as a RAC subunit.

Suggested curator questions:
1. Is the absence of an IRD for GO:0042026 at PTN001065099 an intentional GO_Central decision, or simply un-curated?
2. Should the nucleus correction be handled by an IRD at the propagating node (PTN002500132) or by direct removal on P38788?
3. Are there any downstream tools relying on the UniProt xref snapshot that would re-introduce the removed plasma-membrane term?


Report generated from 3 completed investigation iterations; 6 confirmed findings; 11 papers reviewed. Live GO/PANTHER/QuickGO checks reflect the 2026 snapshot. Withheld local bioinformatics analyses were not available to this run and should be reconciled against this report.

Artifacts